Amenamevir for Treating Acyclovir-Resistant or Refractory Herpes Simplex Virus Infection in Allogeneic Hematopoietic Stem Cell Transplantation Recipients. Two Case Reports

Int J Antimicrob Agents. 2024 Apr 10:107169. doi: 10.1016/j.ijantimicag.2024.107169. Online ahead of print.NO ABSTRACTPMID:38608846 | DOI:10.1016/j.ijantimicag.2024.107169

Source: Herpes - April 12, 2024 Category: Infectious Diseases Authors: L éo Sallée Laetitia Souchet David Boutolleau St éphanie Nguyen Source Type: research